Leerink Partnrs Expects Higher Earnings for Tenet Healthcare

Tenet Healthcare Corporation (NYSE:THC) – Equities researchers at Leerink Partnrs increased their Q3 2026 earnings estimates for Tenet Healthcare in a note issued to investors on Wednesday, July 23rd. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings per share of $3.17 for the quarter, up from their prior estimate of $2.91. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share.

Several other research firms have also commented on THC. Guggenheim boosted their price objective on shares of Tenet Healthcare from $180.00 to $188.00 and gave the stock a “buy” rating in a research report on Wednesday. Stephens upgraded shares of Tenet Healthcare to a “strong-buy” rating in a research report on Monday, June 2nd. Wells Fargo & Company upgraded shares of Tenet Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $150.00 to $195.00 in a research report on Thursday, May 29th. Royal Bank Of Canada boosted their price objective on shares of Tenet Healthcare from $183.00 to $189.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 30th. Finally, The Goldman Sachs Group boosted their target price on shares of Tenet Healthcare from $134.00 to $154.00 and gave the company a “neutral” rating in a research note on Monday, May 5th. Three research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $190.00.

Tenet Healthcare Stock Performance

NYSE:THC opened at $153.01 on Friday. The firm’s fifty day moving average price is $168.17 and its 200 day moving average price is $145.29. Tenet Healthcare has a 1-year low of $109.82 and a 1-year high of $185.25. The company has a debt-to-equity ratio of 2.39, a current ratio of 1.71 and a quick ratio of 1.70. The firm has a market cap of $14.21 billion, a price-to-earnings ratio of 9.80, a price-to-earnings-growth ratio of 0.65 and a beta of 1.64.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Tuesday, July 22nd. The company reported $4.02 EPS for the quarter, beating analysts’ consensus estimates of $2.84 by $1.18. The company had revenue of $5.27 billion for the quarter, compared to analyst estimates of $5.16 billion. Tenet Healthcare had a net margin of 7.17% and a return on equity of 24.69%. Tenet Healthcare’s quarterly revenue was up 3.2% on a year-over-year basis. During the same period in the previous year, the business posted $2.31 earnings per share.

Institutional Investors Weigh In On Tenet Healthcare

Several large investors have recently added to or reduced their stakes in THC. American Century Companies Inc. increased its position in Tenet Healthcare by 16.5% in the fourth quarter. American Century Companies Inc. now owns 34,866 shares of the company’s stock worth $4,401,000 after buying an additional 4,947 shares during the period. KLP Kapitalforvaltning AS acquired a new stake in Tenet Healthcare in the fourth quarter worth $2,777,000. LPL Financial LLC raised its stake in shares of Tenet Healthcare by 40.6% during the fourth quarter. LPL Financial LLC now owns 67,136 shares of the company’s stock valued at $8,475,000 after purchasing an additional 19,389 shares in the last quarter. Prudential Financial Inc. raised its stake in shares of Tenet Healthcare by 8.6% during the fourth quarter. Prudential Financial Inc. now owns 121,509 shares of the company’s stock valued at $15,338,000 after purchasing an additional 9,602 shares in the last quarter. Finally, Norges Bank bought a new stake in shares of Tenet Healthcare during the fourth quarter valued at about $190,819,000. 95.44% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Tenet Healthcare

In related news, Director Richard W. Fisher sold 3,077 shares of the company’s stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $165.72, for a total transaction of $509,920.44. Following the sale, the director directly owned 12,128 shares of the company’s stock, valued at approximately $2,009,852.16. This represents a 20.24% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director J Robert Kerrey sold 5,001 shares of the firm’s stock in a transaction on Friday, May 9th. The stock was sold at an average price of $148.50, for a total value of $742,648.50. Following the transaction, the director owned 22,377 shares in the company, valued at $3,322,984.50. This trade represents a 18.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 54,121 shares of company stock worth $8,846,305. 0.81% of the stock is currently owned by insiders.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.